Dexcom Inc Shareholder Class Action

DexCom and Sprinklr Shareholder Lawsuits

DexCom Inc. Shareholder Class Action

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit filed on behalf of investors in DexCom, Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) for violations of the federal securities laws.

The case, Schall v. DexCom, Inc., et al., was filed in the United States District Court for the Central District of California and alleges that the Company made false and/or misleading statements and/or failed to disclose information pertinent to investors.

DexCom is a global leader in continuous glucose monitoring (CGM) systems for people with diabetes.

Read more at PR Newswire

Sprinklr Inc. Shareholder Class Action

Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of purchasers of Sprinklr, Inc. ("Sprinklr") (NYSE: CXM) common stock between March 17, 2021 and June 27, 2022, for violations of the Securities Exchange Act of 1934.

The complaint alleges that throughout the relevant period, defendants made materially false and/or misleading statements and/or failed to disclose the following material adverse information about Sprinklr's business and financial condition:

• Sprinklr's revenue growth was being driven by unsustainable accounting practices;
• Sprinklr was experiencing significant customer attrition;
• Sprinklr was facing increasing competition from legacy software vendors and start-up companies;
• Sprinklr's financial projections were overly optimistic and did not accurately reflect the Company's true financial condition.

Read more at PR Newswire

Contact:
Scott Wagner
Robbins Geller Rudman & Dowd LLP
655 West Broadway, San Diego, CA 92101
(619) 231-1058
swagner@rgrdlaw.com